Your browser doesn't support javascript.
loading
Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 Omicron subvariant BF.7 among outpatients in Beijing, China.
Yang, Hui; Wang, Zhaojian; Zhang, Ying; Xu, Man; Wang, Yushu; Zhang, Yi; An, Zhuoling; Tong, Zhaohui.
Afiliação
  • Yang H; Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
  • Wang Z; Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China; Department of Clinical Pharmacy, School of Pharmaceutical Science, Capital Medical University, Beijing 100069, China.
  • Zhang Y; Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China; Department of Clinical Pharmacy, School of Pharmaceutical Science, Capital Medical University, Beijing 100069, China; Department of Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Med
  • Xu M; Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China; Department of Clinical Pharmacy, School of Pharmaceutical Science, Capital Medical University, Beijing 100069, China; Department of Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Med
  • Wang Y; Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
  • Zhang Y; Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
  • An Z; Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China. Electronic address: anzhuoling@bjcyh.com.
  • Tong Z; Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing 100020, China. Electronic address: tongzhaohuicy@sina.com.
Vaccine ; 41(48): 7201-7205, 2023 11 22.
Article em En | MEDLINE | ID: mdl-37852869

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China